Today FDA has invited for public comment for the
proposed amendment of its regulations concerning the format and content of the ``Pregnancy'', ``Labor and delivery'', and ``Nursing mothers'' subsections of the ``Use in Specific Populations'' section of the labeling for human prescription drug and biological products
No comments:
Post a Comment